Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$0.29 - $0.45 $56 - $87
195 New
195 $0
Q4 2022

Feb 13, 2023

BUY
$0.97 - $45.0 $475 - $22,050
490 New
490 $0
Q4 2020

Feb 09, 2021

SELL
$5.98 - $12.47 $2,990 - $6,235
-500 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$4.65 - $8.73 $2,325 - $4,365
500 New
500 $3,000
Q2 2020

Aug 10, 2020

SELL
$4.66 - $8.7 $1,118 - $2,088
-240 Closed
0 $0
Q2 2019

Aug 01, 2019

BUY
$11.88 - $16.94 $2,851 - $4,065
240 New
240 $0

Others Institutions Holding DTIL

About PRECISION BIOSCIENCES INC


  • Ticker DTIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 110,818,000
  • Market Cap $584M
  • Description
  • Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...
More about DTIL
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.